GlassScriptPhysician profile
Annu Dixit
NPI 1912564857
$658.22
in general payments reported to CMS, 2019-2025
10 companies · $281 in 2025
The $281 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $106 · 2024: $271 · 2025: $281.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $573 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $573.23 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $149.41 | 2023-2025 | Veozah |
| Shield Therapeutics INC | $131.31 | 2024-2025 | |
| Biogen, INC. | $89.46 | 2025 | Zurzuvae |
| Organon LLC | $70.64 | 2024-2025 | Nexplanon |
| Smith+Nephew, INC. | $57.96 | 2025 | Pico 7 |
| Medtronic, INC. | $49.38 | 2023-2025 | V-Loc 180, Ligasure |
| Exeltis, USA INC. | $40.37 | 2023-2025 | Slynd |
| Myriad Women'S Health, INC. | $34.68 | 2023 | Myrisk |
| Pfizer INC. | $18.62 | 2024 | |
| Molnlycke Health Care US, LLC | $16.39 | 2025 | Avance, Mepilex Border Post-Op Ag |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Annu Dixit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.